Timing of Cancer Drug Efficacy in Mice
Author Information
Author(s): T G Granda, R-M D'Attino, E Filipski, P Vrignaud, C Garufi, E Terzoli, M-C Bissery, F Lévi
Primary Institution: INSERM E-0118 Chronothérapeutique des cancers and Université Paris XI, Institut du Cancer et d'Immunogénétique, Hôpital Paul Brousse, Villejuif, France
Hypothesis
The study investigates how the timing of drug administration affects the efficacy and tolerability of irinotecan and oxaliplatin in mice with Glasgow osteosarcoma.
Conclusion
The timing of drug administration significantly influences the efficacy and tolerability of irinotecan and oxaliplatin in mice.
Supporting Evidence
- Drug efficacy varied significantly based on the time of administration.
- Combining irinotecan and oxaliplatin at optimal times improved survival rates.
- Best tolerability for irinotecan was observed when administered at 7 hours after light onset.
Takeaway
Giving cancer drugs at the right time can make them work better and cause fewer side effects.
Methodology
The study involved administering irinotecan and oxaliplatin to mice at different times of day and measuring tumor growth and survival.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
Male B6D2F1 mice, 6 to 7 weeks of age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website